Patents by Inventor Marc Fisher

Marc Fisher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240399152
    Abstract: Disclosed herein are methods for treating impairment of a limb in a subject. Particular methods comprise applying a therapeutically effective amount of an electrical stimulus to dorsal roots, dorsal rootlets, or dorsal root ganglia, of sensory neurons innervating the limb of the subject, wherein the impairment is a motor impairment and/or a proprioception impairment due to neurological disorder or injury, the electrical stimulus is applied with one or more electrodes controlled by a neurostimulator, and the one or more electrodes are implanted in the epidural space at the dorsolateral aspect of the spinal cord and proximate to the dorsal roots or dorsal rootlets of the sensory neurons innervating the limb of the subject, or the one or more electrodes are implanted proximate to dorsal root ganglia of sensory neurons innervating the limb of the subject.
    Type: Application
    Filed: September 9, 2022
    Publication date: December 5, 2024
    Applicants: University of Pittsburgh - Of the Commonwealth System of Higher Education, CARNEGIE MELLON UNIVERSITY
    Inventors: Marc Philip Powell, Marco Capogrosso, Douglas J. Weber, Nikhil Verma, Peter C. Gerszten, Elvira Pirondini, Erynn Sorensen, Erick Fabrizio Carranza Urquizo, Lee Fisher
  • Publication number: 20240389368
    Abstract: Compositions and mechanisms for the transfer of spin-triplet excitons from a singlet exciton fission material (e.g., tetracene) to an inorganic semiconductor (e.g., n-doped silicon) are provided. The compositions include one or more interlayers, including a charge transfer interlayer (e.g., zinc phthalocyanine), and, optionally, a passivation interlayer (e.g., hafnium oxide, HfO2). The triplet transfer mechanism proceeds via the formation of a charge transfer intermediate state. The transition to the intermediate state is energetically favored by strategically positioned HOMO and/or LUMO levels of the charge transfer interlayer between the singlet fission layer and the inorganic semiconductor. The intermediate state is formed through a transition of either the electron or the hole of the triplet exciton in the charge transfer interlayer (depending, at least in part, on the relative positions of the energy levels) to the conduction or valence band of the inorganic semiconductor, respectively.
    Type: Application
    Filed: October 20, 2022
    Publication date: November 21, 2024
    Inventors: Narumi Nagaya WONG, Collin Fisher PERKINSON, Marc A. BALDO
  • Publication number: 20240286448
    Abstract: A vehicle includes a compensation system for holding and guiding supply lines on the vehicle, the compensation system including a fixed part fixed relative to a frame of the vehicle and a movable part configured to adjust to different positions with respect to the frame, a supply line having a first line end connected to the fixed part and a second line end connected to the movable part, a first end section fixed to the fixed part or the movable part, and a second end fixed to the other of the fixed part and the movable part and configured to prevent sagging of the supply line when a distance between the fixed and movable parts is reduced.
    Type: Application
    Filed: March 24, 2023
    Publication date: August 29, 2024
    Inventors: Arnesh Bose, Justin Fisher, Eric Terpsma, Marc R. Johnson, Lance Gage
  • Patent number: 11811507
    Abstract: A programmable radio frequency (RF) memory system includes a receiver designed to receive an RF pulse, a memory, a waveform transform module, and a transmitter. The memory stores a digitized version of the RF pulse. The waveform transform module is designed to determine one or more characteristics of the digitized version of the RF pulse, and based on the determined one or more characteristics, transform the digitized version of the RF pulse into a transformed signal. The transformed signal has at least one characteristic that is different than the one or more characteristics. The transmitter is designed to transmit an analog equivalent of the transformed signal. The analog equivalent of the transformed signal and the received RF pulse are coherent.
    Type: Grant
    Filed: June 10, 2019
    Date of Patent: November 7, 2023
    Assignee: BAE Systems Information and Electronic Systems Integration Inc.
    Inventors: Austin T. Rios, Marc A. Fisher, Ryan Harding, Patrick R. Kane, Ryan A. Walsh
  • Publication number: 20120070403
    Abstract: The present invention relates to the use of G-CSF and derivatives thereof for extending the therapeutic window of subsequent thrombolytic treatment of acute stroke, and thereby, allowing the diagnostic examinations which are necessary prior to the thrombolytic treatment in order to avoid hemorrhagic and other severe adverse side effects of the thrombolysis.
    Type: Application
    Filed: February 17, 2010
    Publication date: March 22, 2012
    Applicant: SYGNIS BIOSCIENCE GMBH & CO. KG
    Inventors: Marc Fisher, Armin Schneider
  • Publication number: 20080121248
    Abstract: The invention concerns laser decontamination of the surface of a shaped component (3). Said decontamination comprises the following steps: successively impinging parts of the surface of the shaped component (3) with pulsed laser beams of wavelengths in the ultraviolet range and enabling the surface layer of the shaped component (3) to be ablated in the form of particles, the laser beams being distributed so as to cover simultaneously each treated part; and recuperating by suction said particles.
    Type: Application
    Filed: December 12, 2005
    Publication date: May 29, 2008
    Applicant: Compagnie Generale Des Matieres Nuleaires
    Inventors: Bernard Turco, Marc Fisher
  • Patent number: 5872108
    Abstract: The invention is directed to a method of reducing the extent of infarction, particularly cerebral infarction subsequent to cerebral ischemia, by the administration of citicoline shortly after an ischemic episode and continuing daily treatment for up to about 30 days, preferably for at least about 6 weeks. The method is useful in the treatment of stroke and severe head trauma patients and maximizes the chances for a full or substantially full recovery of the patient.
    Type: Grant
    Filed: February 20, 1996
    Date of Patent: February 16, 1999
    Assignee: Interneuron Pharmaceuticals, Inc.
    Inventors: Bobby W. Sandage, Jr., Marc Fisher, Kenneth W. Locke
  • Patent number: 5827832
    Abstract: The invention is directed to a method of reducing the extent of infarction, particularly cerebral infarction subsequent to cerebral ischemia, by the administration of citicoline shortly after an ischemic episode and continuing daily treatment for up to about 30 days, preferably for at least about 6 weeks. The method is useful in the treatment of stroke and severe head trauma patients and maximizes the chances for a full or substantially full recovery of the patient. Combination treatment regimens are also disclosed along with compositions for use therewith.
    Type: Grant
    Filed: March 1, 1996
    Date of Patent: October 27, 1998
    Assignee: Interneuron Pharmaceuticals, Inc.
    Inventors: Bobby W. Sandage, Jr., Marc Fisher, Kenneth W. Locke
  • Patent number: 5801160
    Abstract: Methods and pharmaceutical compositions for reducing the extent of infarction, particularly cerebral infarction subsequent to cerebral ischemia.
    Type: Grant
    Filed: March 18, 1997
    Date of Patent: September 1, 1998
    Assignee: Interneuron Pharmaceuticals, Inc.
    Inventors: Bobby Winston Sandage, Marc Fisher, Kenneth Walter Locke